Hep Email Update NIH Announces New Grant Opportunity for Design of Vaccines Against Hepatitis C Virus A new funding opportunity announcement from the National Institutes of Health will make up to $8 million available for HCV vaccine research. Advertisement FDA Approves Epclusa to Treat Hep C in Children Ages 6 and Up Gilead Sciences’ direct-acting antiviral regimen was previously approved for adults. Tips for Stocking an Emergency Supply of Your Meds During the COVID-19 crisis, some insurers are relaxing their refill rules and allowing 90-day supplies of meds to be prescribed. #Coronavirus Get the latest updates! Hep Spring 2020 Read the latest issue! Hep Stories: Get inspired Advertisement Treatment News FDA Approves Epclusa to Treat Hep C in Children Ages 6 and Up New York State Has a High Rate of Hepatitis C Among Pregnant Women Shortened Epclusa Regimen Not as Effective for Recent Hep C Infection Clinics Need to Increase HIV and Hep C Testing for People Who Inject Drugs Newsfeed CDC Launches Online Coronavirus Symptom Self-Checker Can Chloroquine Prevent or Cure COVID-19? Coronavirus-Driven Restrictions Could Fuel the Opioid Epidemic The Math That Got America to Tackle COVID-19 With Extreme Measures Treatment News FDA Approves Epclusa to Treat Hep C in Children Ages 6 and Up New York State Has a High Rate of Hepatitis C Among Pregnant Women Shortened Epclusa Regimen Not as Effective for Recent Hep C Infection Clinics Need to Increase HIV and Hep C Testing for People Who Inject Drugs Newsfeed CDC Launches Online Coronavirus Symptom Self-Checker Can Chloroquine Prevent or Cure COVID-19? Coronavirus-Driven Restrictions Could Fuel the Opioid Epidemic The Math That Got America to Tackle COVID-19 With Extreme Measures

You are receiving this email because you opted in at one of our websites. At your request, this message was sent to newsletter@newslettercollector.com by update@hepmag.com. Please remember to add update@hepmag.com to your email address book, so that these updates aren't blocked as spam.

To change your subscription information and preferences, please visit your personal preferences page. Or you can unsubscribe completely from this list.

To forward this message, please do not use the forward button of your email application, because this message was made specifically for you only. Instead use the forward page in our newsletter system.

Did you receive this email from a friend? You can subscribe and you will receive our next newsletter directly to your inbox.

Our mailing address is: